A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

Clinical trial NCT05039177 · COMPLETED

Trial details

NCT number: NCT05039177
Sponsor: Erasca, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Metastatic Pancreatic Ductal Adenocarcinoma

Start date: 2021-09-20
Primary completion: 2025-08-15
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.